GCT signs a contract with US pharma company to conduct global phase I-II trial in patients with Peripheral T-Cell Lymphoma
The planned study will be conducted across 17 study sites by GCT in the U.S., Russia and Ukraine.
November 16, 2018
First patient randomized in an international double-blind Phase III cardiac surgery study
The study, sponsored by a European biopharmaceutical company and managed by GCT in Russia has got off the ground. Recently, the leading Russian Cardiology Institute has randomized the first patient in the study.
November 13, 2018
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.